Stock Scorecard
Stock Summary for Quanterix Corp (QTRX) - $5.17 as of 10/29/2025 9:11:47 PM EST
Total Score
11 out of 30
Safety Score
31 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for QTRX
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for QTRX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for QTRX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for QTRX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for QTRX (31 out of 100)
| Stock Price Rating (Max of 10) | 4 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 8 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for QTRX
Financial Details for QTRX
Company Overview |
|
|---|---|
| Ticker | QTRX |
| Company Name | Quanterix Corp |
| Country | USA |
| Description | Quanterix Corporation is a leading life sciences innovator based in Billerica, Massachusetts, focused on revolutionizing precision health through its advanced digital immunoassay platforms. The company's proprietary technology allows for ultra-sensitive biomarker detection, empowering research and diagnostics in a variety of therapeutic areas and driving advancements in disease understanding and personalized patient care. With a strong global presence across North America, Europe, the Middle East, Africa, and Asia Pacific, Quanterix is positioned as a key player in the healthcare and diagnostics sector, committed to transforming patient outcomes and driving innovation in life sciences. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 11/5/2025 |
Stock Price History |
|
| Last Day Price | 5.17 |
| Price 4 Years Ago | 42.40 |
| Last Day Price Updated | 10/29/2025 9:11:47 PM EST |
| Last Day Volume | 692,329 |
| Average Daily Volume | 463,797 |
| 52-Week High | 15.67 |
| 52-Week Low | 4.05 |
| Last Price to 52 Week Low | 27.65% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 45.03 |
| Sector PE | 40.93 |
| 5-Year Average PE | -15.62 |
| Free Cash Flow Ratio | 1.81 |
| Industry Free Cash Flow Ratio | 35.31 |
| Sector Free Cash Flow Ratio | 29.03 |
| Current Ratio Most Recent Quarter | 6.68 |
| Total Cash Per Share | 2.86 |
| Book Value Per Share Most Recent Quarter | 7.52 |
| Price to Book Ratio | 0.90 |
| Industry Price to Book Ratio | 3.99 |
| Sector Price to Book Ratio | 32.16 |
| Price to Sales Ratio Twelve Trailing Months | 2.10 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.62 |
| Sector Price to Sales Ratio Twelve Trailing Months | 16.96 |
| Analyst Buy Ratings | 0 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 46,465,900 |
| Market Capitalization | 240,228,703 |
| Institutional Ownership | 73.48% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -19.17% |
| Reported EPS 12 Trailing Months | -1.81 |
| Reported EPS Past Year | -1.30 |
| Reported EPS Prior Year | -1.03 |
| Net Income Twelve Trailing Months | -70,498,000 |
| Net Income Past Year | -38,531,000 |
| Net Income Prior Year | -32,334,000 |
| Quarterly Revenue Growth YOY | -28.80% |
| 5-Year Revenue Growth | 19.36% |
| Operating Margin Twelve Trailing Months | -86.20% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 132,896,000 |
| Total Cash Past Year | 56,709,000 |
| Total Cash Prior Year | 174,422,000 |
| Net Cash Position Most Recent Quarter | 130,953,000 |
| Net Cash Position Past Year | 49,021,000 |
| Long Term Debt Past Year | 7,688,000 |
| Long Term Debt Prior Year | 7,688,000 |
| Total Debt Most Recent Quarter | 1,943,000 |
| Equity to Debt Ratio Past Year | 0.98 |
| Equity to Debt Ratio Most Recent Quarter | 0.99 |
| Total Stockholder Equity Past Year | 330,038,000 |
| Total Stockholder Equity Prior Year | 346,927,000 |
| Total Stockholder Equity Most Recent Quarter | 292,458,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -32,888,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.71 |
| Free Cash Flow Past Year | -38,532,000 |
| Free Cash Flow Prior Year | -22,690,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.20 |
| MACD Signal | 0.21 |
| 20-Day Bollinger Lower Band | 4.17 |
| 20-Day Bollinger Middle Band | 5.56 |
| 20-Day Bollinger Upper Band | 6.94 |
| Beta | 1.07 |
| RSI | 57.61 |
| 50-Day SMA | 7.25 |
| 150-Day SMA | 14.75 |
| 200-Day SMA | 16.06 |
System |
|
| Modified | 10/28/2025 8:11:42 AM EST |